I Don’t #Smoke or #Drink, I Eat Well & #Exercise. How Did I Still Get #Cancer? An #Oncologist Answers.

Dr. Vishal Rao, an oncologist and head and neck surgeon at the Bangalore-based HealthCare Global (HCG) Cancer Center, writes about the debate on food safety in India and how it is related to cancer. A 45-year-old man presented himself to an oncologist with the typical symptoms of stomach cancer. His worst fears came true, the…Read more I Don’t #Smoke or #Drink, I Eat Well & #Exercise. How Did I Still Get #Cancer? An #Oncologist Answers.

#SunPharma indirect arm to acquire #Thallion Pharmaceuticals

Taro Pharmaceuticals Inc (Canada) has entered into an agreement to acquire all of the issued and outstanding shares of Thallion Pharmaceuticals, a Canadian pharmaceutical corporation, Sun Pharma said in a regulatory filing. Sun Pharmaceuticals Industry today said an indirect arm of its group firm Taro will fully acquire Canada's Thallion Pharmaceuticals for 2.7 million Canadian…Read more #SunPharma indirect arm to acquire #Thallion Pharmaceuticals

If copies of #Teva’s #Copaxone hit, oral MS rivals could be the real threat

​ If forced to use a generic version of Copaxone 40 mg, the follow-up to Teva's previous Copaxone formula, about 70% of patients and doctors would switch to an oral therapy instead, Rob Koremans, Teva’s CEO of global specialty meds, explained on the company’s Q4 conference call. If Teva wins its appeals in patent court, the spending will…Read more If copies of #Teva’s #Copaxone hit, oral MS rivals could be the real threat

Abbott to make India hub of global research and development for branded generics

At a time when multinational drug companies are scaling down their research and development investments in India, citing lax patent rules and increasing regulatory interventions, the US based multinational Abbott is planning to make India its global hub for innovation and development (I&D), in branded generics products. Abbott, the second-largest drug company operating in India…Read more Abbott to make India hub of global research and development for branded generics

Sun Pharma recalls 2.7 lakh bottles of antidepressant in US

Sun Pharma is recalling over 2.7 lakh bottles of bupropion hydrochloride extended-release tablets used for treatment of major depressive disorder in the US due to failed dissolution specifications. The recall is being initiated by Sun Pharmaceutical Industries Inc for 2,71,212 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strengths of 150 mg and…Read more Sun Pharma recalls 2.7 lakh bottles of antidepressant in US

Will not sell sick pharma firms to foreign companies: Government

Amid Opposition protests, government today said it will not sell sick pharma PSUs -- BCPL and HAL -- to foreign firms and closure of IDPL and RDPL will not affect domestic capacities.  There will not be any shortage of medicines in the country because of this move, Minister of State for Fertiliser Mansukh L Mandaviya…Read more Will not sell sick pharma firms to foreign companies: Government

Tata Memorial Hospital to commence two new super specialty courses in oncology and radiology

As part of its mandate to provide trained and qualified human resource in the field of oncology and its related fields, Tata Memorial Hospital (TMH), a comprehensive cancer centre with a mission of service, education and research, is set to launch two super specialty courses in oncology and radiology—Doctorate in Medicine (DM) in Intervention Radiology…Read more Tata Memorial Hospital to commence two new super specialty courses in oncology and radiology